STOCK TITAN

FormFactor (FORM) director Kelley Steven-Waiss sells 2,200 shares at $93.70

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

FormFactor Inc. director Kelley Steven-Waiss reported an open-market sale of common stock. On February 10, 2026, Steven-Waiss sold 2,200 shares of FormFactor common stock at an average price of $93.6995 per share. After this transaction, Steven-Waiss directly owned 30,579 shares of FormFactor common stock.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
STEVEN-WAISS KELLEY

(Last) (First) (Middle)
7005 SOUTHFRONT ROAD

(Street)
LIVERMORE CA 94551

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
FORMFACTOR INC [ FORM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
02/10/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/10/2026 S 2,200 D $93.6995 30,579 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Stan Finkelstein, Attorney-in-fact for Kelley Steven-Waiss 02/11/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did FormFactor (FORM) disclose in this Form 4?

FormFactor disclosed that director Kelley Steven-Waiss sold 2,200 common shares. The transaction occurred on February 10, 2026, as an open-market sale at $93.6995 per share, and is reported as a routine Section 16 insider trading disclosure.

At what price did Kelley Steven-Waiss sell FormFactor (FORM) shares?

The reported sale price was $93.6995 per FormFactor share. This was the average price for the 2,200 shares sold in an open-market transaction on February 10, 2026, as disclosed in the insider trading report.

How many FormFactor (FORM) shares did Kelley Steven-Waiss sell?

Kelley Steven-Waiss sold 2,200 shares of FormFactor common stock. The transaction was coded as a sale in the open market, reflecting a disposal of a portion of the director’s holdings rather than an acquisition or option exercise.

How many FormFactor (FORM) shares does Kelley Steven-Waiss hold after the sale?

After the reported sale, Kelley Steven-Waiss directly owned 30,579 shares. This post-transaction balance reflects continuing direct ownership in FormFactor common stock following the 2,200-share open-market sale on February 10, 2026.

What does the transaction code "S" mean in the FormFactor (FORM) Form 4?

The transaction code "S" indicates a sale of securities. In this case, it identifies the 2,200 FormFactor common shares as sold in an open-market or private sale transaction by director Kelley Steven-Waiss on February 10, 2026.

Is Kelley Steven-Waiss a director or officer of FormFactor (FORM)?

Kelley Steven-Waiss is reported as a director of FormFactor. The filing indicates director status and shows that the reported transaction involves shares held directly, rather than indirectly through another entity or family vehicle.
Formfactor Inc

NASDAQ:FORM

FORM Rankings

FORM Latest News

FORM Latest SEC Filings

FORM Stock Data

7.26B
76.84M
0.98%
99.8%
3.83%
Semiconductor Equipment & Materials
Semiconductors & Related Devices
Link
United States
LIVERMORE